Taisho Pharmaceutical Holdings Co., Ltd.
TAISF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $29,498 | $21,398 | $22,976 | $30,311 |
| Dep. & Amort. | $24,648 | $23,074 | $22,041 | $16,695 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,256 | $1,554 | $3,155 | $7,313 |
| Other Non-Cash | -$11,918 | -$17,520 | -$6,146 | -$12,327 |
| Operating Cash Flow | $40,972 | $28,506 | $42,026 | $41,992 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$50,379 | -$14,389 | -$14,372 | -$9,121 |
| Net Acquisitions | $1,512 | -$4,310 | -$4,084 | -$160,497 |
| Inv. Purchases | -$3,413 | -$1,269 | -$2,068 | -$1,858 |
| Inv. Sales/Matur. | $7,333 | $9,272 | $14,039 | $74,611 |
| Other Inv. Act. | $17,817 | $3,633 | $4,527 | -$10,216 |
| Investing Cash Flow | -$27,130 | -$7,063 | -$1,958 | -$107,081 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,647 | $1,705 | $2,521 | -$525 |
| Stock Repurch. | -$34 | -$43 | -$41 | -$48 |
| Dividends Paid | -$8,206 | -$7,415 | -$8,787 | -$9,586 |
| Other Fin. Act. | -$2,671 | -$2,642 | -$2,559 | -$2,110 |
| Financing Cash Flow | -$10,877 | -$10,057 | -$11,346 | -$11,696 |
| Forex Effect | $1,595 | $780 | -$317 | $177 |
| Net Chg. in Cash | $4,561 | $12,166 | $28,405 | -$76,608 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $227,512 | $215,346 | $186,941 | $263,549 |
| End Cash | $232,073 | $227,512 | $215,346 | $186,941 |
| Free Cash Flow | -$9,407 | $14,117 | $27,654 | $32,871 |